Specialty × MAC Jurisdiction Intelligence
RheumatologyCMS & MAC AlertsWPS Government Health Administrators · Jurisdictions J5, J8
Every CMS transmittal, WPS Government Health Administrators LCD revision, Federal Register notice, and OIG alert affecting Rheumatology billing teams in Indiana, Iowa, Kansas, Michigan, Missouri, Nebraska. Signal-scored and updated daily.
Active alerts
11
Critical / High
4
MAC jurisdiction
J5, J8
Highest-risk CPT
CPT 99213
Recent Rheumatology alerts under WPS Government Health Administrators
4 of the 11 most recent Rheumatology reimbursement alerts are Critical/High-severity for WPS Government Health Administrators (Jurisdictions J5, J8) billing teams. Each links to the source CMS/MAC document with the codes to review and the action to take.
- FDA Approval: XELJANZ (TOFACITINIB) — Type 1 - New Molecular EntityJul 8, 2026
- FDA Approval: XELJANZ XR (TOFACITINIB) — Type 3 - New Dosage FormJul 8, 2026
- FDA Approval: RINVOQ (UPADACITINIB) — Type 1 - New Molecular EntityJul 8, 2026
- FDA Approval: XELJANZ (TOFACITINIB) — Type 3 - New Dosage FormJul 8, 2026
- FDA Approval: OLUMIANT (BARICITINIB) — Type 1 - New Molecular EntityJul 8, 2026
- FDA Approval: RINVOQ (UPADACITINIB) — Type 3 - New Dosage FormJul 8, 2026
- FDA Approval: EXDENSUR (DEPEMOKIMAB) — Type 1 - New Molecular EntityJun 13, 2026
- LCD L39427: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis — CGSCGS Administrators · Jun 5, 2026
- LCD L39481: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis — WPSWPS · Jun 5, 2026
- LCD L39467: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis — NoridianNoridian · Jun 5, 2026
- LCD L39469: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis — NoridianNoridian · Jun 5, 2026
Signal intelligence — Rheumatology × WPS Government Health Administrators
Highest-risk CPT code
CPT 99213
Office visit, established patient, low complexity
View full CPT alert profileWPS Government Health Administrators jurisdiction
J5, J8
Covers Indiana, Iowa, Kansas, Michigan, Missouri, Nebraska. Every rheumatology LCD revision, CMS transmittal, and Federal Register notice affecting these states is signal-scored and surfaced here daily.
View all 11 active alerts for Rheumatology under WPS Government Health Administrators
Full alert text, action recommendations, effective date deadlines, MAC LCD links, and signal score rationale — updated daily.
About WPS Government Health Administrators (Jurisdictions J5, J8)
WPS Government Health Administrators is the Medicare Administrative Contractor responsible for processing Medicare Part A and Part B claims in Jurisdictions J5, J8, covering Indiana, Iowa, Kansas, Michigan, Missouri, Nebraska.WPS Government Health Administrators issues Local Coverage Determinations (LCDs) that define coverage criteria, ICD-10-CM diagnosis code requirements, and CPT billing guidelines for Rheumatology procedures within its jurisdiction. CLV Intelligence monitors WPS Government Health Administrators's LCD publication feed, provider bulletin archives, and CMS contractor-specific transmittals daily.
Rheumatology alerts in other MAC jurisdictions
Get weekly Rheumatology alerts for WPS Government Health Administrators — free
No credit card required. Unsubscribe any time.